Dan Inder Sraow, MD
Interventional Cardiology · Chandler, AZNPI 1588839419
Payments from drug & device makers
Across 179 payments — averaging $83.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$9K
- Abiomed$2K
- Heartflow, Inc.$516
- Philips North America LLC$461
- Medtronic$456
- Abbott$454
- plus $2K from 25 others
What the payments were for
- Consulting fees$5,68838%
- Travel & lodging$2,36716%
- Food & beverage$6,85346%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 48 | $9,003 |
| Abiomed | 21 | $1,785 |
| Heartflow, Inc. | 4 | $516 |
| Philips North America LLC | 7 | $461 |
| Medtronic(3 entities) | 11 | $456 |
| Abbott | 10 | $454 |
| Edwards Lifesciences | 5 | $324 |
| Novartis | 9 | $316 |
| Spinefrontier, Inc. | 1 | $184 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 14 | $179 |
| Biosense Webster, Inc. | 1 | $137 |
| Nalu Medical, Inc. | 5 | $132 |
| Baxter Healthcare | 3 | $116 |
| Covidien LP | 1 | $103 |
| Johnson & Johnson | 7 | $101 |
| AstraZeneca | 5 | $76 |
| Cardiva Medical, Inc. | 3 | $70 |
| Kestra Medical Technology Services, Inc. | 3 | $68 |
| Shockwave Medical, Inc | 1 | $60 |
| Amgen | 3 | $50 |
| Boehringer Ingelheim | 2 | $42 |
| E.r. Squibb & Sons, L.L.C. | 3 | $41 |
| Cordis US CORP. | 2 | $38 |
| Impulse Dynamics (USA) Inc. | 2 | $37 |
| Stryker | 1 | $36 |
| Cleerly, Inc. | 1 | $30 |
| Chiesi USA, Inc. | 2 | $30 |
| Scpharmaceuticals Inc. | 1 | $17 |
| Merck | 1 | $16 |
| Pfizer | 1 | $15 |
| Biotronik Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$6,942
- Impella$1,206
- FFRct$433
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$245
- ELCA$233
- InSpan$184
- SIJFuse$184
- FacetFuse$184
- NanoFuse$184
- CoreValve Evolut$147
- Mitra Clip system$138
- Carto 3$137
- (6571) Eagle Eye$122
- ELUVIA$121
- COREVALVE EVOLUT R$115
- GENERAL VASCULAR INTERVENTION$112
- LEQVIO$104
How this compares
$14,907 in reported general payments places this provider in the 50th percentile of 223 interventional cardiology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 88 | $123,290 |
| EntrestoSacubitril/Valsartan | 73 | $91,860 |
| XareltoRivaroxaban | 66 | $71,897 |
| BrilintaTicagrelor | 42 | $24,890 |
| Repatha SureclickEvolocumab | 16 | $18,875 |
| Metoprolol Succinate | 185 | $2,898 |
| Atorvastatin Calcium | 199 | $1,943 |
| Rosuvastatin Calcium | 142 | $1,930 |
| ClopidogrelClopidogrel Bisulfate | 162 | $1,870 |
| Chlorthalidone | 83 | $1,054 |
| Ranolazine ErRanolazine | 15 | $1,011 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 23 | $874 |
| Furosemide | 128 | $858 |
| Losartan Potassium | 65 | $855 |
| Amlodipine Besylate | 107 | $851 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $15 | $123,29088 claims |
| NovartisEntresto | $316 | $91,86073 claims |
| Johnson & JohnsonXarelto | $101 | $71,89766 claims |
| AstraZenecaBrilinta | $76 | $24,89042 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 223 interventional cardiology providers in Arizona.
Other interventional cardiology in Chandler
- Ashish PershadChandler$1.4M
- Prakash BalanChandler$321K
- Georges NseirChandler$296K
- Pratik DalalChandler$142K
- Abhishek SawantChandler$81K
- Kush AgrawalChandler$44K
- Paul SorajjaPhoenix$8.8M
- Thomas WaggonerTucson$4.1M
- Hursh NaikAvondale$2.2M
- Nabil DibGilbert$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.